Inogen, Inc. (INGN)
6.25
-0.04
(-0.71%)
USD |
NASDAQ |
Oct 16, 16:00
6.16
-0.09
(-1.44%)
After-Hours: 20:00
Inogen Cash from Investing (Quarterly) : -3.134M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.134M |
| March 31, 2026 | -1.975M |
| December 31, 2025 | -1.516M |
| September 30, 2025 | -0.082M |
| June 30, 2025 | -22.57M |
| March 31, 2025 | -2.038M |
| December 31, 2024 | 11.54M |
| September 30, 2024 | 0.305M |
| June 30, 2024 | -12.38M |
| March 31, 2024 | -13.44M |
| December 31, 2023 | 4.128M |
| September 30, 2023 | -45.79M |
| June 30, 2023 | -0.54M |
| March 31, 2023 | -17.11M |
| December 31, 2022 | -6.944M |
| September 30, 2022 | -4.755M |
| June 30, 2022 | 4.874M |
| March 31, 2022 | -4.052M |
| December 31, 2021 | -12.38M |
| September 30, 2021 | 1.154M |
| June 30, 2021 | -4.408M |
| March 31, 2021 | 0.986M |
| December 31, 2020 | -18.52M |
| September 30, 2020 | -7.969M |
| June 30, 2020 | -8.048M |
| Date | Value |
|---|---|
| March 31, 2020 | 8.899M |
| December 31, 2019 | 31.45M |
| September 30, 2019 | -73.68M |
| June 30, 2019 | 5.116M |
| March 31, 2019 | -6.948M |
| December 31, 2018 | 2.00M |
| September 30, 2018 | -9.519M |
| June 30, 2018 | -11.46M |
| March 31, 2018 | -5.989M |
| December 31, 2017 | -3.041M |
| September 30, 2017 | -5.828M |
| June 30, 2017 | -11.80M |
| March 31, 2017 | -3.765M |
| December 31, 2016 | -0.55M |
| September 30, 2016 | -10.69M |
| June 30, 2016 | -1.63M |
| March 31, 2016 | 0.942M |
| December 31, 2015 | -0.476M |
| September 30, 2015 | -6.818M |
| June 30, 2015 | -17.97M |
| March 31, 2015 | -4.04M |
| December 31, 2014 | -4.878M |
| September 30, 2014 | -3.841M |
| June 30, 2014 | -4.307M |
| March 31, 2014 | -3.228M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Inspire Medical Systems, Inc. | 3.548M |
| Stryker Corp. | -639.00M |
| Zimmer Biomet Holdings, Inc. | -190.80M |
| Enovis Corp. | -45.01M |
| Edwards Lifesciences Corp. | -193.20M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 2.946M |
| Cash from Financing (Quarterly) | -5.624M |
| Free Cash Flow | -9.69M |
| Free Cash Flow Per Share (Quarterly) | 0.038 |
| Free Cash Flow to Equity (Quarterly) | 2.168M |
| Free Cash Flow to Firm (Quarterly) | 1.027M |
| Free Cash Flow Yield | -5.71% |